Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1982

1.

Chiral crystal-like droplets displaying unidirectional rotational sliding.

Kajitani T, Motokawa K, Kosaka A, Shoji Y, Haruki R, Hashizume D, Hikima T, Takata M, Yazawa K, Morishima K, Shibayama M, Fukushima T.

Nat Mater. 2019 Jan 21. doi: 10.1038/s41563-018-0270-7. [Epub ahead of print]

PMID:
30664694
2.

The integral function of endocytic recycling compartment is regulated by RFFL-mediated ubiquitination of Rab11 effectors.

Sakai R, Fukuda R, Unida S, Aki M, Ono Y, Endo A, Kusumi S, Koga D, Fukushima T, Komada M, Okiyoneda T.

J Cell Sci. 2019 Jan 18. pii: jcs.228007. doi: 10.1242/jcs.228007. [Epub ahead of print]

PMID:
30659120
3.

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T.

J Clin Oncol. 2019 Jan 18:JCO1800501. doi: 10.1200/JCO.18.00501. [Epub ahead of print]

PMID:
30657736
4.

Association of high levels of plasma OX40 with acute adult T-cell leukemia.

Tanaka Y, Takahashi Y, Tanaka R, Miyagi T, Saito M, Fukushima T.

Int J Hematol. 2019 Jan 16. doi: 10.1007/s12185-018-02580-z. [Epub ahead of print]

PMID:
30652238
5.

Revealing High Oxygen Evolution Catalytic Activity of Fluorine-Doped Carbon in Alkaline Media.

Kim J, Fukushima T, Zhou R, Murakoshi K.

Materials (Basel). 2019 Jan 10;12(2). pii: E211. doi: 10.3390/ma12020211.

6.

Dioxins levels in human blood after implementation of measures against dioxin exposure in Japan.

Muzembo BA, Iwai-Shimada M, Isobe T, Arisawa K, Shima M, Fukushima T, Nakayama SF.

Environ Health Prev Med. 2019 Jan 10;24(1):6. doi: 10.1186/s12199-018-0755-7.

7.

An Adult Case of Herpes Simplex Virus-Associated Granulomatous Encephalitis.

Iwai Y, Nishimura K, Fukushima T, Ito T, Watanabe Y, Noro M, Kuwabara S.

Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2046-18. [Epub ahead of print]

8.

Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine.

Kawaguchi M, Yamamoto K, Takeda N, Fukushima T, Yamashita F, Sato K, Kitamura K, Hippo Y, Janetka JW, Kataoka H.

Commun Biol. 2019 Jan 4;2:11. doi: 10.1038/s42003-018-0255-8. eCollection 2019.

9.

Abscisic Acid Acts as a Regulator of Molecular Trafficking through Plasmodesmata in the Moss Physcomitrella patens.

Kitagawa M, Tomoi T, Fukushima T, Sakata Y, Sato M, Toyooka K, Fujita T, Sakakibara H.

Plant Cell Physiol. 2018 Dec 31. doi: 10.1093/pcp/pcy249. [Epub ahead of print]

PMID:
30597108
10.

Intestinal absorption of the wheat allergen gliadin in rats.

Yokooji T, Fukushima T, Hamura K, Ninomiya N, Ohashi R, Taogoshi T, Matsuo H.

Allergol Int. 2018 Dec 14. pii: S1323-8930(18)30161-8. doi: 10.1016/j.alit.2018.11.005. [Epub ahead of print]

11.

Succinimidyl (3-[(benzyloxy)carbonyl]-5-oxo-1,3-oxazolidin-4-yl)acetate on a triazole-bonded phase for the separation of dl-amino-acid enantiomers and the mass-spectrometric determination of chiral amino acids in rat plasma.

Sakamoto T, Furukawa S, Nishizawa T, Fukuda M, Sasaki M, Onozato M, Uekusa S, Ichiba H, Fukushima T.

J Chromatogr A. 2019 Jan 25;1585:131-137. doi: 10.1016/j.chroma.2018.11.061. Epub 2018 Nov 28.

PMID:
30554776
12.

Supramolecular Packing and Macroscopic Alignment Controls Actuation Speed in Macroscopic Strings of Molecular Motor Amphiphiles.

Leung FK, van den Enk T, Kajitani T, Chen J, Stuart MCA, Kuipers J, Fukushima T, Feringa BL.

J Am Chem Soc. 2018 Nov 21. doi: 10.1021/jacs.8b10778. [Epub ahead of print]

13.

Hereditary clear cell meningiomas in a single family: three-cases report.

Inoue T, Shitara S, Ozeki M, Nozawa A, Fukao T, Fukushima T.

Acta Neurochir (Wien). 2018 Dec;160(12):2321-2325. doi: 10.1007/s00701-018-3727-1. Epub 2018 Nov 13.

PMID:
30421029
14.

Effects of Physical-Agent Pain Relief Modalities for Fibromyalgia Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Honda Y, Sakamoto J, Hamaue Y, Kataoka H, Kondo Y, Sasabe R, Goto K, Fukushima T, Oga S, Sasaki R, Tanaka N, Nakano J, Okita M.

Pain Res Manag. 2018 Oct 1;2018:2930632. doi: 10.1155/2018/2930632. eCollection 2018. Review.

15.

Posteromedial release combined with arthrodesis of the talocalcaneal and calcaneocuboid joints for equinovarus associated with myelodysplasia: Clinical outcomes assessment preliminary report.

Watanabe H, Fukushima T, Taki N, Sugawara R, Inoue H, Takeshita K, Kikkawa I.

J Orthop Sci. 2018 Nov 1. pii: S0949-2658(18)30301-4. doi: 10.1016/j.jos.2018.09.023. [Epub ahead of print]

PMID:
30392713
16.

Crohn's disease manifesting as ileo-urachal fistula: Two cases reports and review of literatures.

Kuroki H, Sugita A, Koganei K, Tatsumi K, Futatsuki R, Obara N, Arai K, Fukushima T.

Int J Surg Case Rep. 2018;53:70-74. doi: 10.1016/j.ijscr.2018.10.031. Epub 2018 Oct 26.

17.

Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair.

Fukushima T, Uchiyama S, Tanaka H, Kataoka H.

Int J Mol Sci. 2018 Nov 1;19(11). pii: E3435. doi: 10.3390/ijms19113435. Review.

18.

Induced-fit expansion and contraction of a self-assembled nanocube finely responding to neutral and anionic guests.

Zhan YY, Kojima T, Nakamura T, Takahashi T, Takahashi S, Haketa Y, Shoji Y, Maeda H, Fukushima T, Hiraoka S.

Nat Commun. 2018 Oct 31;9(1):4530. doi: 10.1038/s41467-018-06874-y.

19.

Heat-Triggered Crystallization of Liquid Crystalline Macrocycles Allowing for Conductance Switching through Hysteretic Thermal Phase Transitions.

Muraoka T, Shima T, Kajitani T, Hoshino N, Morvan E, Grélard A, Dufourc EJ, Fukushima T, Akutagawa T, Nabeya K, Kinbara K.

Chem Asian J. 2019 Jan 4;14(1):141-148. doi: 10.1002/asia.201801372. Epub 2018 Nov 26.

PMID:
30371022
20.

Rewriting the phase diagram of a diamagnetic liquid crystal by a magnetic field.

Hajjaj F, Kajitani T, Ohsumi H, Tanaka Y, Kato K, Takata M, Kitazawa H, Arima TH, Aida T, Fukushima T.

Nat Commun. 2018 Oct 25;9(1):4431. doi: 10.1038/s41467-018-06976-7.

21.

Characteristics of muscle function and the effect of cachexia in patients with haematological malignancy.

Fukushima T, Nakano J, Ishii S, Natsuzako A, Hirase T, Sakamoto J, Okita M.

Eur J Cancer Care (Engl). 2018 Oct 25:e12956. doi: 10.1111/ecc.12956. [Epub ahead of print]

PMID:
30357948
22.

Effects of Aerobic and Resistance Exercises on Physical Symptoms in Cancer Patients: A Meta-analysis.

Nakano J, Hashizume K, Fukushima T, Ueno K, Matsuura E, Ikio Y, Ishii S, Morishita S, Tanaka K, Kusuba Y.

Integr Cancer Ther. 2018 Dec;17(4):1048-1058. doi: 10.1177/1534735418807555. Epub 2018 Oct 23.

23.

Gastric cancer initially presenting as bone metastasis: Two case reports and a literature review.

Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Sakamoto A, Mamiya K, Koizumi T.

Oncol Lett. 2018 Nov;16(5):5863-5867. doi: 10.3892/ol.2018.9393. Epub 2018 Sep 4.

24.

IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.

Furuta H, Yoshihara H, Fukushima T, Yoneyama Y, Ito A, Worrall C, Girnita A, Girnita L, Yoshida M, Asano T, Komada M, Kataoka N, Chida K, Hakuno F, Takahashi SI.

Oncotarget. 2018 Sep 21;9(74):33871-33883. doi: 10.18632/oncotarget.26049. eCollection 2018 Sep 21.

25.

Low-intensity exercise therapy with high frequency improves physical function and mental and physical symptoms in patients with haematological malignancies undergoing chemotherapy.

Fukushima T, Nakano J, Ishii S, Natsuzako A, Sakamoto J, Okita M.

Eur J Cancer Care (Engl). 2018 Nov;27(6):e12922. doi: 10.1111/ecc.12922. Epub 2018 Oct 12.

PMID:
30311313
26.

Terminal Functionalization with a Triptycene Motif That Dramatically Changes the Structural and Physical Properties of an Amorphous Polymer.

Ishiwari F, Okabe G, Ogiwara H, Kajitani T, Tokita M, Takata M, Fukushima T.

J Am Chem Soc. 2018 Oct 17;140(41):13497-13502. doi: 10.1021/jacs.8b09242. Epub 2018 Oct 8.

PMID:
30281289
27.

Predicting falls from behavioral and psychological symptoms of dementia in older people residing in facilities.

Sato S, Kakamu T, Hayakawa T, Kumagai T, Hidaka T, Masuishi Y, Endo S, Fukushima T.

Geriatr Gerontol Int. 2018 Nov;18(11):1573-1577. doi: 10.1111/ggi.13528. Epub 2018 Sep 19.

PMID:
30230170
28.

Sensing the chirality of various organic solvents by helically arranged π-blades.

Shimizu Y, Shoji Y, Hashizume D, Nagata Y, Fukushima T.

Chem Commun (Camb). 2018 Oct 30;54(87):12314-12317. doi: 10.1039/c8cc06277c.

PMID:
30221285
29.

Specific and Oriented Encapsulation of Fullerene C70 into a Supramolecular Double-Decker Cage Composed of Shape-Persistent Macrocycles.

Kawano SI, Fukushima T, Tanaka K.

Angew Chem Int Ed Engl. 2018 Nov 5;57(45):14827-14831. doi: 10.1002/anie.201809167. Epub 2018 Oct 9.

PMID:
30215877
30.

Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.

Nakao T, Fukushima H, Fukushima T, Suzuki R, Hosaka S, Yamaki Y, Kobayashi C, Iwabuchi A, Imagawa K, Sakai A, Shinkai T, Masumoto K, Sakashita S, Masumoto T, Mizumoto M, Sumazaki R, Sakurai H.

Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):442-450. doi: 10.1016/j.rpor.2018.08.006. Epub 2018 Sep 5.

PMID:
30197580
31.

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.

Ohki K, Kiyokawa N, Saito Y, Hirabayashi S, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fukushima K, Hasegawa D, Fukushima H, Imai M, Kajiwara R, Koike T, Komori I, Matsui A, Mori M, Moriwaki K, Noguchi Y, Park MJ, Ueda T, Yamamoto S, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Takahashi H, Fukushima T, Hayashi Y, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2019 Jan;104(1):128-137. doi: 10.3324/haematol.2017.186320. Epub 2018 Aug 31.

32.

Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A.

BMC Musculoskelet Disord. 2018 Aug 18;19(1):297. doi: 10.1186/s12891-018-2217-1.

33.

Life in company dormitories and a career change are associated with anxiety over lack of privacy among radiation decontamination workers in Fukushima Prefecture, Japan.

Hidaka T, Kakamu T, Endo S, Sato S, Masuishi Y, Kumagai T, Nakano S, Koyama K, Fukushima T.

J Occup Health. 2018 Sep 26;60(5):361-368. doi: 10.1539/joh.2018-0007-OA. Epub 2018 Jul 27.

34.

Characteristics of facial expression recognition ability in patients with Lewy body disease.

Kojima Y, Kumagai T, Hidaka T, Kakamu T, Endo S, Mori Y, Tsukamoto T, Sakamoto T, Murata M, Hayakawa T, Fukushima T.

Environ Health Prev Med. 2018 Jul 18;23(1):32. doi: 10.1186/s12199-018-0723-2.

35.

Amino acid analyses of the exosome-eluted fractions from human serum by HPLC with fluorescence detection.

Onozato M, Tanaka Y, Arita M, Sakamoto T, Ichiba H, Sadamoto K, Kondo M, Fukushima T.

Pract Lab Med. 2018 Apr 22;12:e00099. doi: 10.1016/j.plabm.2018.e00099. eCollection 2018 Nov.

36.

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.

Asada S, Goyama S, Inoue D, Shikata S, Takeda R, Fukushima T, Yonezawa T, Fujino T, Hayashi Y, Kawabata KC, Fukuyama T, Tanaka Y, Yokoyama A, Yamazaki S, Kozuka-Hata H, Oyama M, Kojima S, Kawazu M, Mano H, Kitamura T.

Nat Commun. 2018 Jul 16;9(1):2733. doi: 10.1038/s41467-018-05085-9.

37.

Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.

Fukushima T, Kawaguchi M, Yamamoto K, Yamashita F, Izumi A, Kaieda T, Takezaki Y, Itoh H, Takeshima H, Kataoka H.

Cancer Sci. 2018 Sep;109(9):2970-2979. doi: 10.1111/cas.13732. Epub 2018 Aug 16.

38.

Occupational Exposure Limits for ethylidene norbornene, ethyleneimine, benomyl, and 2,3-epoxypropyl methacrylate, and classifications on carcinogenicity.

Committee for Recommendation of Occupational Exposure Limits, Japan Society for Occupational Health, Araki A, Azuma K, Endo G, Endo Y, Fukushima T, Hara K, Hori H, Horie S, Horiguchi H, Ichiba M, Ichihara G, Ikeda M, Ishitake T, Ito A, Ito Y, Iwasawa S, Kakumu T, Kamijima M, Karita K, Katoh T, Kawai T, Kawamoto T, Kumagai S, Kusaka Y, Matsumoto A, Miyagawa M, Miyauchi H, Morimoto Y, Nagano K, Naito H, Nakajima T, Nakano M, Nomiyama T, Okuda H, Okuda M, Omae K, Sakurai H, Sato K, Sobue T, Suwazono Y, Takebayashi T, Takeshita T, Takeuchi A, Takeuchi A, Tanaka M, Tanaka S, Tsukahara T, Tsunoda M, Ueno S, Ueyama J, Umeda Y, Yamamoto K, Yamano Y, Yamauchi T, Yano E.

J Occup Health. 2018 Jul 25;60(4):333-335. doi: 10.1539/joh.2018-0137-OP. Epub 2018 Jul 6. No abstract available.

39.

Thermodynamics of ionic liquid evaporation under vacuum.

Horike S, Ayano M, Tsuno M, Fukushima T, Koshiba Y, Misaki M, Ishida K.

Phys Chem Chem Phys. 2018 Aug 22;20(33):21262-21268. doi: 10.1039/c8cp02233j.

PMID:
29952385
40.

Mechanistic Study of Highly Efficient Direct 1,2-Carboboration of Alkynes with 9-Borafluorenes.

Shoji Y, Shigeno N, Takenouchi K, Sugimoto M, Fukushima T.

Chemistry. 2018 Sep 6;24(50):13223-13230. doi: 10.1002/chem.201801818. Epub 2018 Aug 7.

PMID:
29923245
41.

Impact of helical organization on the photovoltaic properties of oligothiophene supramolecular polymers.

Ouchi H, Kizaki T, Yamato M, Lin X, Hoshi N, Silly F, Kajitani T, Fukushima T, Nakayama KI, Yagai S.

Chem Sci. 2018 Mar 12;9(15):3638-3643. doi: 10.1039/c7sc05093c. eCollection 2018 Apr 21.

42.

Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization.

Nakahara K, Fuchino K, Komano K, Asada N, Tadano G, Hasegawa T, Yamamoto T, Sako Y, Ogawa M, Unemura C, Hosono M, Ito H, Sakaguchi G, Ando S, Ohnishi S, Kido Y, Fukushima T, Dhuyvetter D, Borghys H, Gijsen HJM, Yamano Y, Iso Y, Kusakabe KI.

J Med Chem. 2018 Jul 12;61(13):5525-5546. doi: 10.1021/acs.jmedchem.8b00011. Epub 2018 Jun 14.

PMID:
29775538
43.

Evaluation of two prognostic indices for adult T-cell leukemia/lymphoma in the subtropical endemic area, Okinawa, Japan.

Tamaki K, Morishima S, Nomura S, Nishi Y, Nakachi S, Kitamura S, Uchibori S, Tomori S, Hanashiro T, Shimabukuro N, Tedokon I, Morichika K, Taira N, Tomoyose T, Miyagi T, Karimata K, Ohama M, Yamanoha A, Tamaki K, Hayashi M, Uchihara JN, Ohshiro K, Asakura Y, Kuba-Miyara M, Karube K, Fukushima T, Masuzaki H.

Cancer Sci. 2018 Jul;109(7):2286-2293. doi: 10.1111/cas.13641. Epub 2018 Jun 16.

44.

Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain.

Fuchino K, Mitsuoka Y, Masui M, Kurose N, Yoshida S, Komano K, Yamamoto T, Ogawa M, Unemura C, Hosono M, Ito H, Sakaguchi G, Ando S, Ohnishi S, Kido Y, Fukushima T, Miyajima H, Hiroyama S, Koyabu K, Dhuyvetter D, Borghys H, Gijsen HJM, Yamano Y, Iso Y, Kusakabe KI.

J Med Chem. 2018 Jun 28;61(12):5122-5137. doi: 10.1021/acs.jmedchem.8b00002. Epub 2018 May 23.

PMID:
29733614
45.

Supramolecular scaffolds enabling the controlled assembly of functional molecular units.

Ishiwari F, Shoji Y, Fukushima T.

Chem Sci. 2018 Jan 19;9(8):2028-2041. doi: 10.1039/c7sc04340f. eCollection 2018 Feb 28. Review.

46.

Late-Stage Functionalization of Arylacetic Acids by Photoredox-Catalyzed Decarboxylative Carbon-Heteroatom Bond Formation.

Sakakibara Y, Ito E, Fukushima T, Murakami K, Itami K.

Chemistry. 2018 Jul 2;24(37):9254-9258. doi: 10.1002/chem.201802143. Epub 2018 May 30.

PMID:
29718551
47.

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Int J Clin Oncol. 2018 Oct;23(5):965-973. doi: 10.1007/s10147-018-1281-8. Epub 2018 Apr 26.

PMID:
29700636
48.

EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.

Toriyama E, Imaizumi Y, Taniguchi H, Taguchi J, Nakashima J, Itonaga H, Sato S, Ando K, Sawayama Y, Hata T, Fukushima T, Miyazaki Y.

Int J Hematol. 2018 Aug;108(2):167-175. doi: 10.1007/s12185-018-2455-x. Epub 2018 Apr 12.

PMID:
29651666
49.

Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer.

Fukushima T, Wakatsuki Y, Kobayashi T, Sonehara K, Tateishi K, Yamamoto M, Masubuchi T, Yoshiike F, Hirai K, Hachiya T, Koizumi T.

Cancer Chemother Pharmacol. 2018 Jun;81(6):1043-1050. doi: 10.1007/s00280-018-3573-0. Epub 2018 Apr 11.

PMID:
29644460
50.

Negative and positive control ranges in the bacterial reverse mutation test: JEMS/BMS collaborative study.

Kato M, Sugiyama KI, Fukushima T, Miura Y, Awogi T, Hikosaka S, Kawakami K, Nakajima M, Nakamura M, Sui H, Watanabe K, Hakura A.

Genes Environ. 2018 Apr 4;40:7. doi: 10.1186/s41021-018-0096-1. eCollection 2018.

Supplemental Content

Loading ...
Support Center